Calendar

Allstate had a reported positive EPS revision trend and prior-quarter underwriting strength, but the checked sources disagreed materially on Q3 consensus values and did not establish a positive revenue revision. Recent shares were down, closes were weak within their daily ranges, and volume did not show accumulation; the modest estimate signal is insufficient for a pre-event surprise setup.

MetLife had constructive Q3 EPS estimate revisions and solid Q2 operating momentum, with consensus revenue growth also forecast. The stock had weakened over the latest five sessions, lacked a qualifying close location or volume surge, and no upward revenue revision or specific revenue surprise signal was verified; the setup is therefore incomplete.

Aflac’s stock has risen over the past month and had a qualifying close location on Oct 27, but the checked sources show a slight prior-quarter EPS miss and supply consensus rather than positive estimate revisions or a revenue-upside signal; recent volume also does not qualify.

Edwards reported Q2 sales growth and raised full-year sales guidance, and the October 28 close was in the upper portion of its daily range. However, sources checked for the November 4 date describe it as estimated, not company-confirmed; moreover, no positive current EPS/revenue estimate revision or unusual volume was verified.

The company confirmed a Nov 4 after-close Q3 release, and available sources show EPS and revenue consensus estimates. However, no positive estimate revisions or revenue upside evidence was found; VMRK fell 1.6% over five sessions, underperformed the S&P 500, and Oct 28 volume was below normal. Merger integration is a disclosed risk, so this is not a qualifying surprise setup.

COHR's October 26-28 rebound lifted the close to $239.59, with a strong October 27 close location, and its prior company guidance described substantial growth and margin expansion. However, verified pre-event positive estimate revisions/revenue upside and a recent 1.5x volume session are absent; the tape also includes a sharp October 22 decline. It remains a non-qualifying partial setup.

The prior quarter showed strong commerce, fintech, and advertising growth, but the available pre-event estimate report says consensus EPS was revised 0.62% lower over 30 days, and I found no supported positive revenue revision or usable dated price/volume and sector tape. The Nov. 4 date is estimated by the independent calendar sources rather than confirmed there; insufficient signal for inclusion.

UCB closed October 20 at $35.47, up 5.0% on the earnings-release day, so some improvement is already reflected in price (https://oicharts.com/us/stocks/UCB). The operating EPS result matched the cited FactSet consensus. No reliable post-print analyst target or estimate revision was established by this early T+1 review; zero-valued sentiment fields denote unavailable measurements, not neutral readings. The stored earnings-document row concerns another bank and was excluded.

The release shows strong revenue but a weak Q4 profit outlook, shifting the prior positive thesis toward cautious monitoring. Early coverage reports a premarket dip tied to guidance; a settled T+1 price reaction is not established against the packet's October 20 anchor. [Investing.com](https://au.investing.com/news/stock-market-news/united-airlines-falls-on-weak-fourth-quarter-guidance-4702383) Verified post-print analyst revisions remain unavailable. Social, options, short-interest and employee measures are unavailable; their zero fields denote missing data, not neutral readings.

The positive deterministic prior reflects a meaningful earnings update, but the October 20 close of $73.36 was down 1.19% despite the EPS beat. That muted negative reaction is consistent with investor concern about expenses and reserves, though its cause is not established. One reported Jefferies reiteration is available; a broader analyst-revision series is not. Social, options, short-interest and employee measures are unavailable, and their zero values above are placeholders, not observations. [October 20 price history](https://stockanalysis.com/stocks/syf/history/) [Jefferies coverage](https://www.investing.com/news/analyst-ratings/jefferies-reiterates-synchrony-financial-stock-rating-on-earnings-beat-93CH-4959867)

The initial reaction was negative: Investing.com reported a 3.4% after-hours decline on October 20 and roughly 4% pre-open weakness on October 21, linked to the earnings misses. [Initial reaction](https://ca.finance.yahoo.com/news/pegasystems-falls-third-quarter-misses-205409063.html) [Pre-open reaction](https://ng.investing.com/news/stock-market-news/why-is-pegasystems-stock-sliding-today-93CH-2747612) Citizens reiterated Market Perform, but a reliable post-print target or estimate-revision series is not available. The $36.23 anchor predates the full October 21 session; whether the initial decline holds is unconfirmed. Social, options, short-interest, and employee-sentiment measures are unavailable in the packet.

The initial response was favorable: the October 20 price quote of $37.56 was up about 2.9%, alongside coverage of an adjusted EPS beat. That is an initial reaction, not proof it will hold. Verified post-print analyst revisions were unavailable at this T+1 check. The packet's sole stored earnings-document row concerns TCBX, not PEBO, and was excluded. Social, options, short-interest, and employee sentiment were not evidenced; zero entries above denote unavailable data, not neutral readings. Sources: https://www.investing.com/news/transcripts/earnings-call-transcript-peoples-bancorp-beats-q3-2026-eps-forecast-shares-rise-93CH-4960656 and https://www.sec.gov/Archives/edgar/data/318300/000031830026000231/exhibit991q32026.htm

The earnings release confirms an EPS beat, but management's credit and funding cautions temper it. The $46.16 anchor is the October 20 close, not a post-release reaction; a reliable post-print price move was not established. No verified post-print analyst revision was found. Social, options, short-interest, and employee measures were unavailable; zero fields denote missing data, not neutral readings. The packet's deterministic positive directional prior and elevated thesis-change score warrant reassessment, but its low evidence-quality score and unresolved credit questions favor monitoring rather than a bullish upgrade.